Back
Speaker illustration

Associate Professor David Peter Kao

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

Member of:

European Society of Cardiology

Dr. Kao is an academic cardiologist and Medical Director of the Colorado Center for Personalized Medicine (CCPM) and of UCHealth CARE Innovation Center. He studied biomedical engineering and graduated from medical school at the Johns Hopkins University followed by internal medicine residency and biomedical informatics research fellowship at Stanford. He moved to Colorado in 2008 for cardiology fellowship and subsequently joined the faculty. He has been involved in biomedical research since 1996 and has > 100 peer-reviewed publications and holds the Jacqueline Marie Schauble Leaffer Endowed Chair in Women’s Heart Disease. He uses his clinical experience and informatics expertise to combine and leverage very large clinical datasets in order to close critical gaps in knowledge regarding presentation, natural history and management of congestive heart failure with a specific focus on women with HF. He has been a part of the UCHealth electronic health record and digital health teams as wel

Presentations

Latent class analysis of echocardiographic phenotypes predicts adverse outcomes and treatment response in heart failure with preserved ejection fraction

Event: Heart Failure 2019

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Access
Like
Thumbnail

Spironolactone reduces all-cause mortality in women but not men with heart failure with preserved ejection fraction enrolled in TOPCAT from the Americas

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: Moderated Poster session 6 - Therapy

Access
Like
Thumbnail

Latent class echocardiographic phenotypes predict adverse outcomes in heart failure with preserved ejection fraction: A secondary analysis of TOPCAT

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: HFpEF - Heart failure with preserved ejection fraction

Access
Like
Thumbnail

Sex differences in long-term health status in heart failure with preserved ejection fraction

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: HFpEF - Heart failure with preserved ejection fraction

Access
Like
Thumbnail

Heart rate reduction or ventricular reverse remodeling associated with beta-blocker therapy is accompanied widespread, distinct changes in the beta1-adrenergic receptor gene signaling network

Event: HEART FAILURE 2016

Topic: Beta blockers

Session: Beta blockers

Access
Like
Thumbnail

Association of anemia and transfusion with adverse outcomes in 22,991 patients hospitalized with takostsubo cardiomyopathy

Event: HEART FAILURE 2016

Topic: Cardiomyopathies

Session: Cardiomyopathy

Access
Like
Thumbnail

Race differences in timing of presentation in 1137 peripartum cardiomyopathy patients compared with 2.1 million delivering mothers without peripartum cardiomyopathy

Event: HEART FAILURE 2016

Topic: Cardiomyopathies

Session: Cardiomyopathy

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources